The speed of revenue erosion after patent expiry depends on four variables: the number of generic entrants, the therapeutic category, the channel mix, and whether the innovator deploys an authorized generic
Trulicity is a once-weekly sugar control injection used in adults with type 2 diabetes
The worldwide GLP-1 Receptor Agonist Market Size is expected to reach USD 24.2 Billion by 2032
Identity and quality are confirmed by batch documentation COA, plus HPLC / MS where applicable before material is released
For many GLP-1 users, that makes it a safer first Starbucks breakfast than a big sandwich or sweet drink
Healthcare systems recognized semaglutide as a cost-effective intervention compared to obesity-related complications like type 2 diabetes, cardiovascular disease, and joint deterioration